Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use DOXORUBICIN HYDROCHLORIDE safely and effectively. See full prescribing information for DOXORUBICIN HYDROCHLORIDE. DOXORUBICIN HYDROCHLORIDE injection, for intravenous use Initial U.S. Approval: 1974
Medication labelWhy this: Advisory · dailymed-prescription
Doxorubicin Hydrochloride Injection is indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer. Doxorubicin Hydrochloride Injection is indicated for the treatment of •acute lymphoblastic leukemia •acute myeloblastic leukemia •Hodgkin lymphoma •non-Hodgkin lymphoma (NHL) •metastatic breast cancer •metastatic Wilms' tumor •metastatic neuroblastoma •metastatic soft tissue sarcoma •metastatic bone sarcoma •metastatic ovarian carcinoma •metastatic transitional cell bladder carcinoma •metastatic thyroid carcinoma •metastatic gastric carcinoma •metastatic bronchogenic carcinoma
- generic_name
- doxorubicin hydrochloride
- product_names
- Doxorubicin Hydrochloride
- ndc
- 0069-3030, 0069-3030-20, 0069-3031, 0069-3031-20, 0069-3032, 0069-3032-20, 0069-3033, 0069-3033-20, 0069-3034, 0069-3034-20, 0069-0358, 0069-0358-20, 0069-0277, 0069-0277-02, 0069-0343, 0069-0343-02, 0069-1542, 0069-1542-20
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en